.jpg){kind=logo}
Targeted clinical solutions engineered for metabolic acidosis management, non-calcium phosphate regulation, uremic toxin reduction, and nephroprotection during dialysis and advanced CKD.
Precision formulations supporting renal therapy, hemodialysis balance, and metabolic equilibrium.
Calcium-free phosphate binding (SEVPARI-400) preventing vascular calcification and mineral disorders.
Standard & Enteric-coated Sodium Bicarbonate (SODIFIX & PARINSODA-EC) for systemic pH balance and GI comfort.
Standard & Double Strength Alpha Ketoanalogues (KETONF & KETONF DS) to reduce nitrogenous waste burden.
Potent antioxidant N-Acetylcysteine (NCTYL) protecting renal parenchymal tissue against oxidative injury.
A non-calcium, non-aluminum phosphate binder designed for hyperphosphatemia management in adult CKD and dialysis patients. It selectively binds dietary phosphate in the digestive tract without increasing systemic calcium load, preventing vascular calcification and cardiovascular complications.
A clinical-grade metabolic acidosis therapy for chronic kidney disease. SODIFIX replenishes serum bicarbonate reserves, effectively counteracting systemic metabolic acidosis, preserving residual glomerular function, and alleviating fatigue and muscular wasting in renal patients.
A standard keto-analogue and essential amino acid formulation engineered for chronic renal insufficiency management. KETONF converts endogenous nitrogen waste into non-toxic essential amino acids, delaying dialysis onset and preventing protein malnutrition during low-protein diets.
KETONF – DS is a specialized nutritional therapy for patients with Chronic Kidney Disease (CKD Stages 3 & 4). Formulated with calcium-based keto-analogues and essential amino acids, it provides full essential amino acid nutrition while actively reducing toxic urea accumulation and cutting daily pill burden by 50%.
A powerful antioxidant and intracellular glutathione precursor providing targeted nephroprotection. NCTYL scavenges cytotoxic reactive oxygen species (ROS), protecting fragile renal tissues against contrast-induced nephropathy (CIN), ischemia-reperfusion injury, and oxidative stress.
Parinyogine Healthcare supplies high-purity dialysis drugs and nephrology therapeutics across hospitals, dialysis centers, and clinical networks. Request clinical studies, dosage guides, or institutional supply details.
